Time & Location
09 Dec, 10:00 – 11:00 GMT
Registration is required from Genesis special site.
WEBINAR – login details will be sent to all registered delegates for Genesis 2020 closer to the date of the webinar
Japan as a New Investment Target for Life Science Innovation
Following the recent EPA (Economic Partnership Agreement) between Japan and the UK, Japan is attracting more interest among international investors, especially for what concerns life-science innovation ventures. LINK-J (Life Science Innovation Network Japan), one of the most active Japanese life-science ecosystems partnering with OneNucleus, invites four leading Japanese startups to pitch their technologies at the Innovation Workshop.
10.00 - Welcome from the Hosts
Masashi Matsunaga, Oxentia (LINK-J supporter)
10:05 – Introduction to LINK-J, Japan’s most active life science innovation ecosystem
Aki Soyama, LINK-J
10:15 - Four presentations will follow from:
Revolutionizing the Way We Treat Heart Failure ~ Development of novel cell-based therapeutics and a delivery method towards a FIH trial
Ami Okuno, Metcela
An innovative nasal vaccine targeting infectious diseases
Pohsing Ng, HanaVax
Cellular Technology Breakthroughfor Clear Vision of the Future
Shin Hatou, Cellusion Inc.
Surgical Database S access
Akihiro Hirao, Surg Storage Inc.
11.00 – Close